Table 2:
MRI, Brain |
CT, Head |
PET, Brain | SPECT, Brain | MRS, Head | fMRI, Head | |||
---|---|---|---|---|---|---|---|---|
Without Contrast | Without and With Contrast | Without Contrast | Without and With Contrast | |||||
Suspected HD | 8 | 7 | 5 | 3 | 5a | 5a | 3 | 2 |
Clinical features suggestive of NBIA | 8 | 7 | 5 | 4 | 3a | 3a | 3 | 3 |
Parkinson's disease: typical clinical features and responds to levodopa | 7a | 7a | 6 | 5 | 6a,b | 6a,c | 3 | 2 |
PD syndrome: atypical clinical features not responsive to levodopa | 8 | 7 | 5 | 4 | 6a | 6a | 3 | 2 |
Note:—MRI indicates MR imaging; MRS, MR spectroscopy; fMRI, functional MRI. Appropriateness criteria scale from 1 to 9; 1, least appropriate; 9, most appropriate.
For problem solving.
Dopa PET.
Specific ligand.